NASDAQ:DMAC

Diamedica Therapeutics Stock Predictions

etoro logo Buy DMAC
*Your capital is at risk
$5.65
-0.120 (-2.08%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

DMAC Prediction Chart

DMAC Predictions History

Latest community submissions for DMAC.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jul 12, 2023 $3.41 -3.67% $3.80 X 89.74% 0
Jul 12, 2023 $3.67 +3.79% $3.80 V 96.69% 1
Jul 12, 2023 $3.62 +2.37% $3.80 V 95.36% 1
JS JS Pro
Jul 7, 2023 $4.10 +1.49% $3.93 X 95.67% 0
Jul 7, 2023 $4.17 +3.26% $3.93 X 93.85% 0
Jul 7, 2023 $4.12 +2.04% $3.93 X 95.10% 0
JS JS Pro
Jun 29, 2023 $4.23 +0.24% $4.24 V 99.76% 6
Jun 29, 2023 $4.09 -3.14% $4.24 X 96.40% 0
Jun 29, 2023 $4.14 -1.96% $4.24 X 97.58% 0
JS JS Pro
Jun 27, 2023 $4.33 -1.59% $4.25 V 98.12% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for DMAC with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT DIAMEDICA THERAPEUTICS INC.
DiaMedica Therapeutics
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE